Under the terms of the agreement, the product may be introduced in the US in February 2025 after receiving FDA approval.
The price band for Mukka Proteins IPO is between ₹26 to ₹28 per equity share, with a lot size of 535 shares and multiples thereafter
According to a press release from Suven Pharmaceuticals, the entire deal is anticipated to be completed within the next 12 to 15 months
Aurobindo Pharma markets its products in over 125 countries, with key partners like AstraZeneca and Pfizer
The public offer exclusively comprises a fresh issue of up to 8 crore equity shares, with no offer-for-sale (OFS) component.
The US private equity group is trying to employ financial consultants.
During the IPO, which concluded on February 26th, the price band was set between ₹177 and ₹186 per share.
A total of six investors participated in the anchor book
The retail investor portion of Mukka Proteins' initial public offering (IPO) has been subscribed 3.65 times
The share buyback is set to conclude on March 6, according to the company's stock exchange filing.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
